CVRdatabase
Menu

Ensoma ApS

Private limited companyCVR 40804307København ØActive

Ensoma ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2019. The company made a loss in both 2024 and 2025, most recently DKK 1.2m. Equity fell to DKK 912k in 2025. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 835k+75.5% vs. 2024
Net profit−DKK 1.2m+78.7% vs. 2024
EquityDKK 912k−55.9% vs. 2024
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 5.4m to DKK 1.2m (2024 → 2025).
  • Equity fell 56% (2024 → 2025), to DKK 912k.

Employees

  • 18 fewer employees than a year earlier: 2 (03/2025) against 20 (03/2024).

Management and owners, last 24 months

  • New in management: Magnus Glissmann Bojer-Larsen (director, 08/05/2026), Anders Anton Maier (board member, 08/05/2026) and Chapman McCann Wright (board member, 01/07/2026).
  • Stepped down: Stefano Stella (director, 08/05/2026) and Elinor Kyonghae Shin (board member, 01/07/2026).

Registrations, last 24 months

  • 06/05/2026: Moved to Sundkrogsgade 21, 2100 København Ø
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 6m−DKK 5m−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1mDKK 2m202020212022202320242025
EquityNet profit
Financial figures for Ensoma ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−620−1,272−2,078−1,955−3,407−835+75.5%
Operating profit (EBIT)−861−2,201−3,427−3,865−6,155−1,148+81.4%
Profit before tax−863−2,222−3,483−3,879−6,161−1,154+81.3%
Net profit−671−1,784−2,914−3,141−5,423−1,154+78.7%
Total assets1,7282,6111,2552,2172,786942−66.2%
Equity1,5172,379−5341,5022,066912−55.9%
Liabilities2112321,79071571931−95.8%
Cash and cash equivalents1,4782,0105008821,112934−16%
Average number of employees2101115172−88.2%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 4m−DKK 3m−DKK 2m−DKK 1mDKK 0DKK 1m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

  • Equity fell sharply

    Equity fell 56% from 2024 to 2025 (DKK 2.1m to DKK 912k).

    How is this calculated?

    Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.

  • Fewer employees

    The number of employees fell 88% from 17 in 2024 to 2 in 2025.

    How is this calculated?

    The number of employees according to the annual report has fallen by at least 25%, and was at least 10 the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Ensoma ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202529/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202416/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202301/07/2024The companyPDFXBRL
202201/01/2022 – 31/12/202216/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202116/05/2022The companyPDFXBRL
202023/09/2019 – 31/12/202029/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
051015202504/2205/2206/2207/2208/2209/2210/2211/2212/2201/2302/2303/2304/2305/2306/2307/2308/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/25
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 835kNo. 321 of 421
Better than 24% of the companies in the industry
EquityDKK 912kNo. 244 of 431
Better than 43% of the companies in the industry
Number of employees2No. 290 of 431
Better than 33% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 68,617of 69,742
Better than 2%
No. 34,881of 69,964
Better than 50%
Same industry and fewer than 20 employees329 companies in the comparison
No. 243of 323
Better than 25%
No. 156of 329
Better than 53%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 33,092of 33,588
Better than 1%
No. 16,074of 33,687
Better than 52%
All companies of type ApS66,508 companies in the comparison
No. 65,506of 66,379
Better than 1%
No. 30,734of 66,505
Better than 54%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Ensoma ApS−DKK 835k
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Ensoma ApS−DKK 1.2m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Ensoma ApSDKK 912k
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Ensoma ApS2
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Ensoma, Inc.100%
Ensoma ApS

Management

4 active registrations

Executive management

Executive management at Ensoma ApS
NameRoleAppointed
Magnus Glissmann Bojer-LarsenDirector08/05/2026

Board of directors

Board of directors at Ensoma ApS
NameRoleAppointed
James William BurnsChair of the board26/06/2024
Anders Anton MaierBoard member08/05/2026
Chapman McCann WrightBoard member01/07/2026
Founders
Guillermo Montoya Blanco, Stefano Stella
Former management (13)
Former management at Ensoma ApS
NameRoleAppointedResigned
Guillermo Montoya BlancoDirector23/09/201926/11/2021
Stefano StellaDirector23/09/201908/05/2026
Guillermo Montoya BlancoBoard member18/09/202008/02/2023
Stefano StellaBoard member18/09/202008/02/2023
Christian SchetterChair of the board18/09/202012/04/2021
John Stephen CassidyBoard member18/09/202027/07/2021
Christian SchetterBoard member13/04/202127/07/2021
Gita Padmavathy DittmarChair of the board13/04/202108/02/2023
Mark David ChinBoard member27/07/202108/02/2023
Emile Fuad NuwaysirChair of the board08/02/202326/01/2024
Min WangBoard member08/02/202326/06/2024
Paula Alex SoteropoulosChair of the board26/01/202424/06/2024
Elinor Kyonghae ShinBoard member26/06/202401/07/2026

Signing rule: Selskabet tegnes af én direktør og et medlem af bestyrelsen i forening eller af den samlede bestyrelse i forening.

Address and production units

1 active production units

Sundkrogsgade 21
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Ensoma ApSSundkrogsgade 21, 2100 København Ø21025059529

Purpose

Selskabets formål er at udvikle og kommercialisere medicinske lægemidler samt anden virksomhed, der står i forbindelse hermed.

The purpose is quoted from the register in Danish.

Changes year by year

75 registered events
20267 changesmanagement 5 · accounts 1 · address 1
  • Chapman McCann Wright appointed board member
  • Elinor Kyonghae Shin stepped down as board member
  • Annual report for 2025 published
  • Anders Anton Maier appointed board member
  • Magnus Glissmann Bojer-Larsen appointed director
  • Stefano Stella stepped down as director
  • Moved to Sundkrogsgade 21, 2100 København Ø
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20248 changesaccounts 1 · management 6 · address 1
  • Annual report for 2023 published
  • James William Burns appointed chair of the board
  • Elinor Kyonghae Shin appointed board member
  • Min Wang stepped down as board member
  • Paula Alex Soteropoulos stepped down as chair of the board
  • Moved to Nordre Fasanvej 215, 2000 Frederiksberg
  • Paula Alex Soteropoulos appointed chair of the board
  • Emile Fuad Nuwaysir stepped down as chair of the board
202314 changesaccounts 1 · name 1 · management 6 · ownership 5 · capital 1
  • Annual report for 2022 published
  • Name changed from Twelve Bio ApS to Ensoma ApS
  • Min Wang appointed board member
  • Emile Fuad Nuwaysir appointed chair of the board
  • Mark David Chin stepped down as board member
  • Gita Padmavathy Dittmar stepped down as chair of the board
  • Guillermo Montoya Blanco stepped down as board member
  • Stefano Stella stepped down as board member
  • ENSOMA, INC. registered as owner (100%)
  • Asteria Holdings ApS is no longer registered as owner
  • GM Holdings ApS is no longer registered as owner
  • BII Holdings A/S is no longer registered as owner
  • Arix Bioscience Holdings Limited is no longer registered as owner
  • Share capital changed from 101,089 DKK to 118,759 DKK
20221 changeaccounts 1
  • Annual report for 2021 published
202117 changesmanagement 7 · accounts 1 · capital 1 · ownership 8
  • Guillermo Montoya Blanco stepped down as director
  • Mark David Chin appointed board member
  • Christian Schetter stepped down as board member
  • John Stephen Cassidy stepped down as board member
  • Annual report for 2020 published
  • Share capital changed from 72,516 DKK to 101,089 DKK
  • Asteria Holdings ApS registered as owner (15%)
  • GM Holdings ApS registered as owner (15%)
  • BII Holdings A/S registered as owner (5%)
  • Arix Bioscience Holdings Limited registered as owner (50%)
  • BII Holdings A/S is no longer registered as owner
  • Arix Bioscience Holdings Limited is no longer registered as owner
  • GM Holdings ApS is no longer registered as owner
  • Asteria Holdings ApS is no longer registered as owner
  • Gita Padmavathy Dittmar appointed chair of the board
  • Christian Schetter appointed board member
  • Christian Schetter stepped down as chair of the board
202020 changesownership 12 · capital 2 · management 4 · name 1 · address 1
  • BII Holdings A/S registered as owner (10%)
  • NOVO NORDISK FONDEN is no longer registered as owner
  • Share capital changed from 40,002 DKK to 72,516 DKK
  • Guillermo Montoya Blanco appointed board member
  • John Stephen Cassidy appointed board member
  • Christian Schetter appointed chair of the board
  • Stefano Stella appointed board member
  • Arix Bioscience Holdings Limited registered as owner (25%)
  • NOVO NORDISK FONDEN registered as owner (10%)
  • GM Holdings ApS registered as owner (25%)
  • Asteria Holdings ApS registered as owner (25%)
  • Asteria Holdings ApS is no longer registered as owner
  • GM Holdings ApS is no longer registered as owner
  • Asteria Holdings ApS registered as owner (50%)
  • GM Holdings ApS registered as owner (50%)
  • Guillermo Montoya Blanco is no longer registered as owner
  • Stefano Stella is no longer registered as owner
  • Name changed from GEBAMO ApS to Twelve Bio ApS
  • Share capital changed from 40,000 DKK to 40,002 DKK
  • Moved to Ole Maaløes Vej 3, 2200 København N
20196 changesaddress 1 · founded 1 · management 2 · ownership 2
  • Moved to Dronningens Tværgade 14, 4. th, 1302 København K
  • Registered as GEBAMO ApS
  • Stefano Stella appointed director
  • Guillermo Montoya Blanco appointed director
  • Guillermo Montoya Blanco registered as owner (50%)
  • Stefano Stella registered as owner (50%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction